Anti-ACACB/ ACC2/ ACCB functional antibody

Anti-ACACB/ ACC2/ ACCB functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ACACB/ACACB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T08922-Ab-1/ GM-Tg-hg-T08922-Ab-2Anti-Human ACACB monoclonal antibodyHuman
GM-Tg-rg-T08922-Ab-1/ GM-Tg-rg-T08922-Ab-2Anti-Rat ACACB monoclonal antibodyRat
GM-Tg-mg-T08922-Ab-1/ GM-Tg-mg-T08922-Ab-2Anti-Mouse ACACB monoclonal antibodyMouse
GM-Tg-cynog-T08922-Ab-1/ GM-Tg-cynog-T08922-Ab-2Anti-Cynomolgus/ Rhesus macaque ACACB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T08922-Ab-1/ GM-Tg-felg-T08922-Ab-2Anti-Feline ACACB monoclonal antibodyFeline
GM-Tg-cang-T08922-Ab-1/ GM-Tg-cang-T08922-Ab-2Anti-Canine ACACB monoclonal antibodyCanine
GM-Tg-bovg-T08922-Ab-1/ GM-Tg-bovg-T08922-Ab-2Anti-Bovine ACACB monoclonal antibodyBovine
GM-Tg-equg-T08922-Ab-1/ GM-Tg-equg-T08922-Ab-2Anti-Equine ACACB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T08922-Ab-1/ GM-Tg-hg-T08922-Ab-2; GM-Tg-rg-T08922-Ab-1/ GM-Tg-rg-T08922-Ab-2;
GM-Tg-mg-T08922-Ab-1/ GM-Tg-mg-T08922-Ab-2; GM-Tg-cynog-T08922-Ab-1/ GM-Tg-cynog-T08922-Ab-2;
GM-Tg-felg-T08922-Ab-1/ GM-Tg-felg-T08922-Ab-2; GM-Tg-cang-T08922-Ab-1/ GM-Tg-cang-T08922-Ab-2;
GM-Tg-bovg-T08922-Ab-1/ GM-Tg-bovg-T08922-Ab-2; GM-Tg-equg-T08922-Ab-1/ GM-Tg-equg-T08922-Ab-2
Products NameAnti-ACACB monoclonal antibody
Formatmab
Target NameACACB
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ACACB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T08922-Ag-1Recombinant multi-species ACACB/ ACC2/ ACCB protein


    Target information

    Target IDGM-T08922
    Target NameACACB
    Gene ID32,100705,116719,706909,100685468,101086680,515338,100066740
    Gene Symbol and SynonymsACACB,ACACbeta,ACC-beta,ACC2,ACCB,ACCbeta,HACC275
    Uniprot AccessionO00763
    Uniprot Entry NameACACB_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000076555
    Target ClassificationN/A

    The target: ACACB, gene name: ACACB, also named as ACC2, ACCB, HACC275. Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis.  ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria.  ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis.  There is evidence for the presence of two ACC-beta isoforms. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.